Understand Why Semglee Will Be “Interchangeable” With Lantus
Semglee (insulin glargine-yfgn U-100) will be the first “interchangeable” biosimilar.
It was originally approved as a new brand of insulin glargine, not a Lantus generic...and switching required a new Rx. Now that’s changing.
Be aware of what an “interchangeable” biosimilar is.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote